The Korean Journal of Internal Medicine10.3904/kjim.2015.2762018331211-213Invasive pulmonary aspergillosis in a patient with metastatic non-small cell lung cancer after treatment with gefitinibSejeong Park, Soyoung Park, Hana Choi, Ji Young Park, Hyo Seok Lim, Myung Jae Park, Si-Young Kim,,
Lung Cancer10.1016/s0169-5002(86)80759-0198624266Possible risk of invasive pulmonary aspergillosis with marijuana use during chemotherpay for small cell lung cancer,
Lung Cancer10.1016/s0169-5002(97)89553-01996161120Treatment of metastatic non-small cell lung cancer,
Lung Cancer10.1016/0169-5002(92)90247-h19928157Necrotizing bronchial aspergillosis in a patient receiving neoadjuvant chemotherapy for non-small cell lung carcinoma,
Lung Cancer: Targets and Therapy10.2147/lctt.s9974201037Standing the test of time in Europe? Gefitinib in the treatment of non-small-cell lung cancer wilson
Lung Cancer10.1016/j.lungcan.2004.10.0122005481141-144Efficacy of the tyrosine kinase inhibitor gefitinib in a patient with metastatic small cell lung cancerJun Araki, Isamu Okamoto, Ryuichiro Suto, Yasuko Ichikawa, Ji-ichiro Sasaki,
Lung Cancer10.1016/s0169-5002(07)70422-1200757S12-S17Improving patient management in metastatic non-small cell lung cancerJohan Vansteenkiste,
Reactions Weekly10.1007/s40278-017-36288-8201716701135-135Gefitinib,,
Lung Cancer10.1016/j.lungcan.2006.04.0042006531123-124Three-year survival in metastatic non-small cell lung cancer treated with gefitinibDaniel B. Costa, Susan T. Schumer,
Yearbook of Pulmonary Disease10.1016/j.ypdi.2012.01.04020122012102-103Treatment of Non–Small-Cell Lung Cancer with Erlotinib or GefitinibL.T. Tanoue,